Data from a 3-year extension of the LiGHT trial show that selective laser trabeculoplasty provides better long-term disease control than initial drop therapy. Selective laser trabeculoplasty (SLT) has been approved to treat glaucoma since 2001, but data on its efficacy as primary therapy are limited. In 2019, the Laser in Glaucoma and Ocular Hypertension (LiGHT) … Continue reading 6-Year Results Support SLT for Glaucoma & Ocular Hypertension